RxDoctor Payments DataLook up a doctor →

Eliza Hough, PA

Medical · Charleston, SCNPI 1780914499

Payments from drug & device makers

$13,400in general payments, 2019–2025

Across 622 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$981
  • Merck$881
  • AstraZeneca$735
  • Pfizer$702
  • Takeda Pharmaceuticals U.S.A., Inc.$690
  • Sanofi$523
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,11298%
  • Education$2882%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis47$981
Merck35$881
AstraZeneca(2 entities)39$735
Pfizer37$702
Takeda Pharmaceuticals U.S.A., Inc.23$690
Sanofi22$523
Bristol Myers Squibb26$518
E.r. Squibb & Sons, L.L.C.31$502
GSK24$500
Johnson & Johnson22$482
Incyte Corporation19$480
Seagen Inc.16$429
Genentech USA, Inc.21$410
Daiichi Sankyo Inc.16$409
Regeneron Healthcare Solutions, Inc.18$383
Amgen18$376
Eisai Inc.14$289
Gilead(2 entities)8$261
Jazz Pharmaceuticals Inc.13$239
AbbVie12$224
Lilly USA, LLC9$212
Taiho Oncology, Inc.10$205
Astellas Pharma US Inc8$173
Alnylam Pharmaceuticals Inc.6$156
Ipsen Biopharmaceuticals, Inc6$137
Beone Medicines USA, Inc.5$135
Acrotech Biopharma Inc.5$130
Rigel Pharmaceuticals, Inc.7$130
Beigene USA, Inc.6$121
Array Biopharma Inc6$92
Tersera Therapeutics LLC4$91
Adaptive Biotechnologies Corporation4$90
Puma Biotechnology, Inc.5$89
Exelixis Inc.5$88
Boehringer Ingelheim3$87
Bayer4$80
Sobi, Inc4$79
AVEO Pharmaceuticals, Inc.3$72
Servier Pharmaceuticals LLC3$71
ADC Therapeutics America, Inc.4$69
Kyowa Kirin, Inc.4$67
Morphosys, US Inc.4$67
Immunocore Limited3$63
Deciphera Pharmaceuticals Inc.3$56
Stemline Therapeutics Inc.2$56
Dova Pharmaceuticals3$51
Legend Biotech USA Inc.1$51
Karyopharm Therapeutics Inc.2$45
Azurity Pharmaceuticals, Inc.2$43
Syndax Pharmaceuticals, Inc.2$41
Pharmaessentia USA Corporation2$41
Myovant Sciences Inc.2$38
Coherus Oncology, Inc.2$37
Shield Therapeutics Inc2$37
CTI Biopharma Corp.2$36
Acceleron Pharma, Inc.2$34
EUSA Pharma (US) LLC1$27
G1 Therapeutics, Inc.1$25
Mirati Therapeutics, Inc.1$24
Forte Bio-pharma LLC1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,400 in reported general payments places this provider in the 95th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$90,393
Medicare patients
305
Services billed
1,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide18$361,993
VerzenioAbemaciclib23$332,331
CalquenceAcalabrutinib Maleate20$270,316
XtandiEnzalutamide24$260,688
EliquisApixaban100$80,634
Abiraterone Acetate12$23,528
XareltoRivaroxaban13$15,334
Exemestane20$4,435
Letrozole73$1,776
Potassium Chloride34$1,054
Acyclovir37$803
Ondansetron Hcl28$654
Anastrozole11$591
Hydroxyurea20$519
Famotidine25$379

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$518$361,99318 claims
Lilly USA, LLCVerzenio$212$332,33123 claims
AstraZenecaCalquence$735$270,31620 claims
Astellas Pharma US IncXtandi$173$260,68824 claims
PfizerEliquis$702$80,634100 claims
Johnson & JohnsonXarelto$482$15,33413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 medical providers in South Carolina.

Other medical in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →